An increase in CX3CL1 expression in a tumor is correlated with the anti-cancer response of the immune system—the accumulation of anticancer CD4+ T cells, CD8+ T cells, dendritic cells and NK cells in a tumor [61,64,69,70,71,72,73,74,75,76,77,78]. The gene discussed is CD8A; the disease is neoplasm.